Clinical Efficacy of Nasal Steroids on Nonallergic Rhinitis and the Associated Inflammatory Cell Phenotypes
- 1 September 2015
- journal article
- research article
- Published by SAGE Publications in American Journal of Rhinology & Allergy
- Vol. 29 (5) , 343-349
Abstract
Background: Although good response to nasal steroid therapy has been documented in allergic rhinitis (AR), the efficacy of this treatment in non-AR, and the associated inflammatory cell phenotypes has not been fully investigated. Objective: To compare the response to steroids in non-AR versus AR and to assess the impact of inflammatory cell phenotypes on non-AR treatment outcomes. Methods: A total of 149 patients with rhinitis were divided into non-AR and AR groups by using the allergy skin-prick test. Based on nasal cytology, the non-AR group was further divided into inflammatory non-AR (INAR) and noninflammatory non-AR (NINAR) groups, and the INAR groups were further subdivided into four phenotypes according to inflammatory cell type: non-AR with eosinophils (NARES), non-AR with mast cells (NARMA), non-AR with neutrophils (NARNE), and NARES and mast cells (NARESMA). All the patients were treated over 28 days with 220 μg of nasal triamcinolone acetonide once daily. Nasal symptom score, peak inspiratory flow index, and nasal mucociliary clearance time (NMCCT) were used to evaluate treatment outcomes. Results: The initial screening found 67 patients with non-AR and 82 patients with AR. At 28 days after nasal steroid treatment, all nasal symptom score, peak inspiratory flow indexes, and NMCCTs were significantly improved within each group; however, the non-AR group recorded significantly lower levels of improvement in blocked nose, rhinorrhea, sneezing, nasal itching, peak flows, and NMCCTs than the AR group. The NINAR group overall indicated lower levels of improvement than the INAR group. Among the INAR subgroups, the NARESMA, NARES, and NARMA phenotypes had similar outcome improvements, all better than the NARNE phenotype. Conclusion: Although both patients with non-AR and those with AR had good steroid response, the patients with non-AR had less improvement than the patients with AR. Patients with NINAR had the worst treatment outcome among the non-AR phenotypes.Keywords
This publication has 27 references indexed in Scilit:
- Role of inflammation in non-allergic rhinitisRhinology journal, 2014
- Characterizing Rhinitis SubtypesAmerican Journal of Rhinology & Allergy, 2013
- Nonallergic rhinitisCurrent Opinion in Allergy and Clinical Immunology, 2013
- Nonallergic RhinitisAmerican Journal of Rhinology & Allergy, 2013
- Vasomotor RhinitisCurrent Allergy and Asthma Reports, 2010
- Evaluation of nasal cytology in subjects with chronic rhinitis: a 7-year studyAmerican Journal of Otolaryngology, 2009
- The diagnosis and management of rhinitis: An updated practice parameterJournal of Allergy and Clinical Immunology, 2008
- Non-Allergic Rhinitis with Eosinophils and Mast Cells Constitutes a New Severe Nasal DisorderInternational Journal of Immunopathology and Pharmacology, 2008
- Update on nonallergic rhinitisAnnals of Allergy, Asthma & Immunology, 2001
- Diagnosis and Management of Rhinitis: Complete Guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and ImmunologyAnnals of Allergy, Asthma & Immunology, 1998